During the past decade, Innovative Spine Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Innovative Spine Care" are "Pain" (2 trials), "Chronic Intractable Pain" (1 trials) and "Radicular Pain" (1 trials). Many other conditions were trialed in "Innovative Spine Care" in a lesser frequency.

Most popular intervention types in "Innovative Spine Care" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fluoroscopy guided transforaminal epidural steroid injection (TFESI)" (1 trials), "Intraspinal Gabapentin" (1 trials), "Perc-DLR/Perc-DLG" (1 trials), "Prialt (ziconotide)" (1 trials) and "Ziconotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Innovative Spine Care" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Innovative Spine Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Innovative Spine Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Innovative Spine Care, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".